BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:38:00 AM | Browse: 1138 | Download: 890
 |
Received |
|
2013-03-28 09:33 |
 |
Peer-Review Started |
|
2013-03-29 10:08 |
 |
To Make the First Decision |
|
2013-05-02 10:35 |
 |
Return for Revision |
|
2013-05-17 16:00 |
 |
Revised |
|
2013-05-30 04:04 |
 |
Second Decision |
|
2013-07-01 12:07 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-07-01 23:44 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-07-11 19:00 |
 |
Publish the Manuscript Online |
|
2013-11-08 10:03 |
Category |
Pediatrics |
Manuscript Type |
Autobiography |
Article Title |
Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Mary P Borgerding, Randall K Absher and Tsz-Yin So |
Funding Agency and Grant Number |
|
Corresponding Author |
Tsz-Yin So, PhD, BCPS, Department of Pharmacy, Moses H. Cone Memorial Hospital, 1200 N. Elm St., Greensboro, NC 27401, United States. jeremy.so@conehealth.com |
Key Words |
Pediatrics; Sickle cell; Tramadol; Morphine; Vaso-occlusive crisis |
Core Tip |
A small clinical study has shown that balanced analgesia using intravenous morphine, intravenous ketorolac, and intravenous tramadol followed by erythrocytapheresis was effective, as shown by pain relief and significant improvement in mood and sleep, in seven sickle cell disease patients aged three to twenty-eight years who presented with vaso-occlusive crisis. The objective of this study is to evaluate whether the addition of scheduled oral tramadol to intravenous morphine plus intravenous ketorolac provides adequate pain relief, and reduces morphine requirements, adverse effects, length of patient-controlled analgesia therapy, and length of hospital stay. |
Publish Date |
2013-11-08 10:03 |
Citation |
Borgerding MP, Absher RK, So TY. Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis. World J Clin Pediatr 2013; 2(4): 65-69 |
URL |
http://www.wjgnet.com/2219-2808/full/v2/i4/65.htm |
DOI |
http://dx.doi.org/10.5409/wjcp.v2.i4.65 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345